Guide: Navigating PCR Billing Challenges in MolDx Jurisdictions
00:00 1X Laboratories performing polymerase chain reaction (PCR)-based diagnostic testing continue to face significant billing and reimbursement challenges, particularly in regions covered by the Molecular Diagnostic Services Program (MolDx). As labs operating...
No Surprises Act Frequently Asked Questions
Federal Surprise Billing Law effective: Jan. 1, 2022 Overview: The No Surprises Act (NSA) provides individuals and families covered by group and individual health plans protection against unexpected, high-priced medical bills for services delivered at in-network...
What is Alternative Proficiency Testing? Understanding CLIA Requirements
00:00 1X Federal regulations require clinical laboratories to routinely assess the accuracy and reliability of their testing processes. But what happens when no commercial Proficiency Testing (PT) program exists for a particular analyte your lab performs? In...
Guide: Efficient Infectious Disease Testing & New Diagnostic Strategies
As infectious diseases continue to pose serious threats to public health worldwide, the demand for accurate, rapid, and scalable diagnostic testing has never been greater. From managing common infections to responding to global health emergencies, laboratories play a...
Lighthouse Acquires MJB Lab Consulting, Expanding Medical Leadership Services